FDA PMA Approved 🇺🇸 United States

Pulmonary Valve Prosthesis Percutaneously Delivered

PMA: P200015 · Supplement: S020 · Decision Aug 8, 2022
Classifications
1
FEI Numbers
14
Registration Numbers
14

Basic Information

Device Name
Pulmonary Valve Prosthesis Percutaneously Delivered
Trade Name
Edwards Alterra Adaptive Prestent System
PMA Number
P200015
Supplement Number
S020
Product Code
NPV
Generic Name
Pulmonary valve prosthesis percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 8, 2022
Date Received
April 25, 2022
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for a new e-beam sterilizer for the Alterra Adaptive Prestent System.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPV Pulmonary Valve Prosthesis Percutaneously Delivered